Science · 24 views
Popular weight-loss drugs Ozempic and Wegovy may slow biological aging
Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging.
AI Summary
Research has identified a potential link between the active ingredient in certain weight-loss medications and biological aging. The study, which focused on adults with HIV, found that semaglutide slowed markers of biological aging. This is the first clinical evidence suggesting that the medication may influence human aging. While the findings are promising, scientists emphasize the need for further research before drawing conclusions about the medication's effects on aging.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Science
Continue reading recent Science coverage
- One of America's Most Widely Consumed Ingredients Linked to Metabolic Changes And ObesityContinue reading
- As Star Trek turns 60, it’s not too late to discover the seminal seriesContinue reading
- Kauai on tornado watch as Hurricane Lowell nears Hawaiian IslandsContinue reading
- The danger of viewing the cosmos as a mirror that shows us ourselvesContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow